In response to the COVID-19 pandemic, the DC CFAR is announcing a special cycle of pilot awards on COVID-19 and HIV. The Rapid Response Research Awards on COVID-19 and HIV will provide pilot funds to early stage and new HIV/AIDS investigators to collect preliminary data that will further our scientific understanding of the relationships between the coronavirus and HIV epidemics with an emphasis on Washington, DC.
Faculty investigators at eight participating DC CFAR institutions (American University, Children's National Health System, DC Health, Georgetown University, George Washington University, Howard University, Veterans Affairs Medical Center, and Whitman-Walker Health) who are full members of the DC CFAR are eligible to apply as Principal Investigators (PI) to the program. These funds are provided to support early stage and new HIV/AIDS investigators. Principal Investigators must have a doctoral degree and be eligible to submit NIH grant applications through their home institution’s office of research. PIs must be at the rank of Assistant Professor, Associate Professor, Full Professor or Research Scientist. New investigators are those who have not previously served as the PI on a R01 NIH award or equivalent (for more information, please visit the NIH guidance on investigator types). Clinical and post-doctoral fellows are not eligible to apply as PIs.
This Rapid Response Research Awards fund projects with a focus on the COVID-19 pandemic and HIV/AIDS in a wide range of scientific disciplines, including social and behavioral science; clinical, mental health and epidemiologic studies; and laboratory sciences. Clinical trials and studies involving new drugs, treatments, or devices cannot be funded by the DC CFAR. Applicants should 1) describe how they will use DC CFAR Core services in their proposed research projects and 2) demonstrate how their research project relates to, and could impact, the COVID-19 and HIV/AIDS epidemics in the District of Columbia. To focus on the local community that we serve, applications should focus on the epidemics in DC. Priority will be given to projects that can be conducted in a timely manner.
District of Columbia Center for AIDS Research
Supported by the following Co-Funding and Participating Institutes: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. (P30AI117970)